360 ONE Asset acquires stake in OneSource Specialty Pharma

360 ONE Asset has acquired a stake in OneSource Specialty Pharma, a Contract Development and Manufacturing Organization (CDMO), for an undisclosed amount. The investment will support OneSource's innovation and global expansion plans. OneSource recently raised $95 million from other investors and is preparing to list its shares on stock exchanges.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QHh09nE
via IFTTT

Read More

How long sitting hours harm your health and how to avoid it

Incorporating movement and ergonomic adjustments into your routine can counteract the harmful effects of sitting. Small, consistent changes can significantly improve your overall well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rRe9Hq8
via IFTTT

Read More

About 18% of deaths in 2019 attributable to air pollution: ICMR study

A report by India's leading health research body found that air pollution caused 1.7 million deaths in 2019. This represents 18% of all deaths in the country that year. The primary cause of death was chronic obstructive pulmonary disease (COPD). The study identified industrial emissions, vehicular exhaust, and the burning of solid fuels as major contributors to air pollution.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6uS1Cwy
via IFTTT

Read More

Project SPECS of WHO will soon be implemented in Assam

The World Health Organization (WHO) is partnering with Sri Sankaradeva Nethralaya (SSDN) to launch the SPECS project in Assam, India. This pilot program aims to provide comprehensive eye care services, focusing on refractive errors, in three districts. The initiative will leverage SSDN's community-based approach and serve as a model for WHO's global efforts to improve eye health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fSTY5bm
via IFTTT

Read More

Wockhardt chairman seeks GST exemption for antibiotics discovered in India

Wockhardt founder sought GST exemption for antibiotics discovered in India. He said this will make the drugs more affordable. The statement was made at an event to celebrate the scientific completion of the first indigenously developed antibiotic Nafithromycin. Nafithromycin is the first macrolide antibiotic in 30 years for community-acquired bacterial pneumonia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/l5WrHTC
via IFTTT

Read More

High pollution may boost demand for respiratory drugs

"The respiratory market shows the normal seasonal trend for the anti-asthma and cough and cold segment," said Sheetal Sapale, VP, commercial, Pharmarack. "There were fewer reported cases in October 2024 compared to October 2023, hence there is de-growth in the market. The market peaks in December and January and then gradually subsides as winter loses its intensity," Sapale said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qt0vgsj
via IFTTT

Read More

Covid shots: Parents seek vaccine courts to ensure 'swift' justice

Parents of children who allegedly died from COVID-19 vaccine side effects are demanding justice and transparency in public health policies. They are calling for faster legal proceedings and a revamped system for reporting adverse events following immunization.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3HOrCEA
via IFTTT

Read More

Tired eyes? Try these 7 yoga poses for better vision naturally

These yoga asanas can help relax the eyes, strengthen eye muscles, and improve vision naturally. Regular practice, combined with a healthy lifestyle, can yield lasting benefits.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iUm4y0A
via IFTTT

Read More

Glenmark to focus on becoming branded company, says Glenn Saldanha

Glenmark Pharmaceuticals, having navigated recent challenges, is shifting its focus to branded products for higher profit margins. The company, aiming for a 12%-15% growth rate, divested its active pharmaceutical ingredient business to concentrate on branded pharmaceuticals, particularly in respiratory, dermatology, and oncology.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FkqJe5o
via IFTTT

Read More

Biocon Biologics looks to trim $300 million debt in 1 year

Biocon Biologics plans to reduce its acquisition debt by $300 million over the next year. The company recently refinanced $1.1 billion in debt, providing more financial flexibility. Biocon aims to capitalize on the growing insulin market, with plans to double its insulin production capacity in Malaysia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VUW7gHT
via IFTTT

Read More

Supreme Court asks Zydus Lifesciences to approach Delhi HC over ban on selling breast cancer drug Sigrima

The Supreme Court has instructed Zydus Lifesciences to approach the Delhi High Court. Zydus is seeking relief from an order that prevents the sale of its breast cancer drug, Sigrima. Swiss pharmaceutical giant, Roche, alleges that Sigrima is similar to its own cancer drug. Roche requested the court to prohibit Zydus from selling Sigrima.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bCA6GZF
via IFTTT

Read More

Morning walks in high pollution: Safe or risky? How to stay active safely

While morning walks are often associated with numerous health benefits, they may not be safe during periods of high air pollution. By adapting your routine and staying informed about air quality, you can maintain an active lifestyle without risking your well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZhMrECV
via IFTTT

Read More

Dr Reddy's, FDC recall products in US for manufacturing issues

Dr Reddy's Laboratories and FDC Ltd issued voluntary recalls for medications in the US market due to manufacturing defects. Dr Reddy's recalled lots of Morphine Sulfate extended-release tablets due to failed impurity specifications, while FDC Ltd recalled Timolol Maleate ophthalmic solution due to defective containers hindering solution dispensing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vgHbkZK
via IFTTT

Read More

Menopause is hot: How celebrities and startups are transforming women's health

Menopause is having a moment, with celebrities and entrepreneurs capitalizing on the growing global market for menopause-related products and services. Indian women are also seeking solutions, leading to a surge in femtech startups offering everything from supplements and digital platforms to community support, aiming to break the taboo surrounding menopause.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/10N7xs9
via IFTTT

Read More

Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the way

Telangana's Genome Valley is attracting substantial investments in life sciences. Over Rs. 36,000 crore was invested in the past year. This resulted in over 140 new projects. These projects include pharmaceutical manufacturing, R&D centers, and vaccine production. International companies are partnering with Indian businesses. The government expects these investments to create thousands of jobs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OPGcH5
via IFTTT

Read More

6 health benefits of drinking black coffee without sugar every day

Black coffee is a simple, calorie-free beverage with numerous health advantages. By skipping sugar, it becomes a powerhouse of nutrients and compounds that promote overall wellness. Here are six key benefits of drinking black coffee without sugar:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/XEmecAI
via IFTTT

Read More

Diabetes too serious to be left to medical professionals only: Jitendra Singh

India is tackling its diabetes epidemic head-on. At the 52nd Annual Conference of the Research Society for the Study of Diabetes in India, experts stressed the need for public-private partnerships to address the disease affecting over 10 crore Indians.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5lqofW8
via IFTTT

Read More

7 surprising ways to use tea beyond drinking you didn't know about

Discover 7 surprising ways to use tea beyond just drinking! From reducing puffy eyes and fighting dandruff to deodorizing your home and repelling pests, these creative tea hacks will transform your routine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/S0XVsA3
via IFTTT

Read More

Want to add beetroot to your diet? Here are 7 healthy & colorful recipes for every meal

Beetroot is a nutrient-packed vegetable known for its rich color and health benefits. Here are seven delicious and healthy beetroot recipes to enjoy throughout the day.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/f9ZbEgi
via IFTTT

Read More

India has the highest number of diabetic people in the world, even more than China: Report

A new study reveals that over 800 million adults worldwide have diabetes. India leads the world with 212 million cases, followed by China with 148 million. The US has 42 million cases. The global diabetes rate has doubled since 1990. The study used data from over 140 million people across more than 1,000 studies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fbr1clT
via IFTTT

Read More

US-based AptarGroup breaks ground for new pharma plant in Taloja, near Mumbai

AptarGroup held a groundbreaking ceremony for a new pharmaceutical plant in Taloja, India. The facility expands AptarGroup's presence in the region. The plant will produce pressurized metered dose inhaler valves, breath-actuated devices, and single-dose nasal sprays. The company is exploring acquisitions to expand its drug delivery offerings.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FVuA4em
via IFTTT

Read More

Pharma market sees 6.1% growth in October despite subdued volumes

Amongst the top 10 therapies that contribute to more than 90% of the Indian pharma market, price drove growth in the cardiac segment. The anti-hypertensives, which account for almost 50% of the cardiac segment, is experiencing stagnated volume growth. Lipid-lowering drugs and platelet aggregation inhibitors have shown a relatively higher growth to help boost the cardiac segment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9gUHqbF
via IFTTT

Read More

Neem or curry leaves for healthier hair: Which works better?

Neem and curry leaves are popular natural ingredients for hair care, each offering unique benefits. Neem is known for its powerful antifungal and antibacterial properties, while curry leaves are rich in nutrients that strengthen and promote hair growth. Here’s a comparison to help you decide which might be better for your hair needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uiPE9JK
via IFTTT

Read More

Diabetes and heart health: Acting early

Type 2 diabetes significantly elevates the risk of heart disease, making individuals more susceptible to heart attacks, strokes, and heart failure. Early management is crucial, focusing on blood sugar control, blood pressure and cholesterol management, weight loss, and lifestyle modifications. This proactive approach can provide long-term heart health benefits, known as the "legacy effect."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ylBWEub
via IFTTT

Read More

Alembic Pharmaceuticals gets USFDA nod for generic hypertension treatment capsules

Alembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride extended-release capsules. These capsules, available in strengths of 120 mg to 360 mg, are designed to treat hypertension and manage angina. This approval grants Alembic access to an estimated market valued at USD 105.3 million annually.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yXOLMB6
via IFTTT

Read More

TA Associates to acquire majority stake in Vee Healthtek for $250 m

US private equity firm TA Associates is set to acquire a majority stake in Vee Healthtek, an Indian revenue cycle management firm, for $250 million. The deal marks TA's entry into India's RCM market and its second investment in the country's healthcare IT sector.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/R51ofd2
via IFTTT

Read More

Winter superfoods: 8 dry fruits and seeds to eat, their benefits, and ideal portions

Discover 8 dry fruits and seeds to boost your health this winter. Learn their benefits and the ideal servings for enhanced immunity, energy, and overall well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wKAbOS9
via IFTTT

Read More

Medical devices industry welcomes government's Rs 500-crore scheme

India's medical device industry is celebrating a new ₹500 crore government scheme designed to boost domestic manufacturing and reduce reliance on imports. The scheme will fund key initiatives such as manufacturing essential components, developing shared infrastructure, and supporting clinical studies, ultimately aiming to position India as a global leader in medical technology.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/twC7jDc
via IFTTT

Read More

Hashimoto's disease explained: Arjun Kapoor's battle, symptoms, and risks

Arjun Kapoor opens up about his struggle with Hashimoto’s disease, an autoimmune disorder affecting the thyroid. This slideshow explores the symptoms, risk factors, and what the condition entails for Kapoor.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/q15MALr
via IFTTT

Read More

Which weight loss method is most effective: Fasting, early eating, or fewer meals?

This research compares three popular weight-loss methods: intermittent fasting, eating earlier in the day, and consuming fewer meals. All methods show similar results, so choose the one that fits your lifestyle.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FDoWMLq
via IFTTT

Read More

Labour Ministry enters into MoU with Cygnus Ujala to enhance employability in the healthcare sector

The Ministry of Labour and Employment has partnered with Cygnus Ujala to boost healthcare job opportunities on the National Career Service (NCS) portal. This collaboration aims to add 25 lakh vacancies, focusing on Tier II and Tier III cities, with an emphasis on women's employment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ik1GdsX
via IFTTT

Read More

NPPA asks companies to cut prices of three cancer drugs post tax relief

In a move aimed at providing relief to cancer patients, the National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturers to reduce the maximum retail price (MRP) of three crucial cancer drugs. This directive follows the government's decision to exempt Trastuzumab Deruxtecan, Osimertinib, and Durvalumab from Customs duty and reduce GST rates on these medications.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7QJvgN8
via IFTTT

Read More

Medanta enters O&M for 750 bed super specialty hospital in New Delhi; to invest Rs 600 crore

Global Health, the company behind Medanta hospitals, has partnered with Dr. Narayan Dutt Shirmali Foundation to manage a new 750-bed super specialty hospital in Pitampura, New Delhi. The hospital, expected to open in four years, represents a Rs. 600 crore investment for Medanta and will offer a wide range of specialized medical services.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mX7YhRp
via IFTTT

Read More

OmniActive Health acquires botanical ingredients company ENovate Biolife

OmniActive Health Technologies, a Mumbai-based nutraceutical company, has acquired ENovate Biolife, a developer of botanical ingredients. This acquisition, funded through internal accruals, marks OmniActive's second strategic expansion. OmniActive aims to double its revenue to ₹2,000 crores within the next 5 to 6 years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5NkcLRy
via IFTTT

Read More

Health groups raise concerns over patents for rare disease drugs

Health groups and patient advocates are raising concerns over patent monopolies on rare disease drugs in India. They argue that these monopolies, like the one held by Roche for the spinal muscular atrophy drug Risdiplam, restrict access to affordable medication.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/i1HIR4y
via IFTTT

Read More

Venus Remedies gets GMP approval for pre-filled syringe facility

Indian pharmaceutical company Venus Remedies received a significant approval from the Malaysian authorities. The company's Baddi facility, equipped with advanced robotic technology, met the stringent quality standards for producing pre-filled syringes. This recognition paves the way for Venus Remedies to expand its global presence and provide critical medications to more countries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mJBNakw
via IFTTT

Read More

CDSCO may regulate health supplements to stem unapproved claims by firms

A government panel in India is proposing stricter regulations on health claims made by supplement manufacturers. The panel suggests shifting control from the food safety authority to the drug regulator, aiming to curb exaggerated claims related to disease treatment or risk reduction.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ichOSme
via IFTTT

Read More

US firm Alkomex to expand R&D footprint in India

Global pharmaceutical company Alkomex GBN is expanding its research and development operations into India. The company has appointed nutraceuticals expert Dr. Sanjay Agrawal as Scientific Advisor to lead these efforts. Based in Ahmedabad, Dr. Agrawal will oversee research and strategic initiatives, integrating Indian research into Alkomex's global operations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/O0euwlI
via IFTTT

Read More

FSSAI sets stricter rule for antibiotics in food items

"If enforced strictly, the regulations will ensure safer food products for consumers by setting stricter residue and contaminant limits across a variety of food items and help in dealing with antimicrobial resistance," said George Cheriyan, working president of Consumers Protection Association (CPA). The FSSAI has also prohibited the use of antibiotics during honey production and reset the limit of the chemicals ochratoxin A and deoxynivalenol in wheat, wheat bran, barley, rye and coffee.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Z6CwgT3
via IFTTT

Read More

Bajra roti or wheat roti? Which is better for health and weight loss?

Choosing bajra roti over wheat can be a great step toward better health and well-being. Here are the key benefits of choosing bajra roti over wheat for a healthier lifestyle.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/H0mS6M3
via IFTTT

Read More

Dr Reddy's recalls over 3.3 lakh bottles of generic medication in US: USFDA

Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets in the US due to manufacturing issues. The recall is due to the presence of an impurity above FDA limits. The recall affects 30 mg, 60 mg, and 90 mg strengths, with the affected lot produced in India. The recall was initiated on October 9, 2023.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DIbUnKx
via IFTTT

Read More

Apollo Hospitals announces Rs 1,625 crore expansion in Mumbai and Lucknow

Apollo Hospitals announces a major expansion plan in Mumbai and Lucknow with a total investment of Rs 1625 crore over the next four years. The expansion, involving a 500-bed facility in Worli and a 200-bed extension in Lucknow, will be funded through internal accruals and debt financing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gVjTe08
via IFTTT

Read More

From fish to seeds: 5 excellent sources of Omega-3 fats for a healthier diet

Omega-3 fatty acids are essential fats that play a crucial role in maintaining heart health, supporting brain function, and reducing inflammation. While fatty fish are well-known sources, there are several other foods you can include in your diet to ensure you’re getting enough omega-3s. Here are five excellent sources to consider:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7aJrhny
via IFTTT

Read More

Suven, Cohance aim to double combined business revenue to Rs 6,000 cr by FY29

Suven Pharmaceuticals and Cohance Lifesciences plan to merge and aim to double their revenue to Rs 6,000 crore by FY29 through organic and inorganic growth. The merger has received NSE and BSE approvals, with a shareholders meeting scheduled for November 28, 2024. The combined entity will focus on pharma CDMO, specialty chemicals CDMO, and APIs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ITczxfL
via IFTTT

Read More